Proteomic time course of breast cancer cells highlights enhanced sensitivity to Stat3 and Src inhibitors prior to endocrine resistance development

To prevent the development of endocrine-resistant breast cancer, additional targeted therapies are increasingly being trialled in combination with endocrine therapy. The molecular mechanisms facilitating cancer cell survival during endocrine treatment remain unknown but could help direct selection o...

Descripción completa

Detalles Bibliográficos
Autores principales: Madden, Stephen F., Cremona, Mattia, Farrelly, Angela M., Low, Weng Hei, McBryan, Jean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935392/
https://www.ncbi.nlm.nih.gov/pubmed/36266450
http://dx.doi.org/10.1038/s41417-022-00548-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935392/
https://www.ncbi.nlm.nih.gov/pubmed/36266450
http://dx.doi.org/10.1038/s41417-022-00548-0

Ejemplares similares